Partnerships

– Clinical Research Collaborations
– In-Licensing
– Companion Diagnostics
– Physician Education
– Third Party Testing

Educating physicians on the clinical utility and interpretation of molecular diagnostics tests can have a significant impact on improving patient outcomes from targeted cancer therapies. 

MolecularMD has partnered with a variety of pharmaceutical companies and non-profit CME organizations to create and support physician education programs.  These programs demonstrate the benefit and proper interpretation of molecular diagnostic test results.  The contributions are reviewed by our own clinical research advisory board for accuracy and clarity.